Evaxion A (EVAX) Interest Expenses (2020 - 2026)

Evaxion A (EVAX) reported Interest Expenses of -$332000.0 for Q1 2026, up 16.37% on a YoY basis from -$285290.0 in Q1 2025, and up 87.92% quarter-over-quarter from -$2.7 million in Q4 2025.

Evaxion A (EVAX) Interest Expenses (2020 - 2026) Analysis & Trends

Evaxion A has reported Interest Expenses for 7 years, with the latest figure at -$332000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Interest Expenses rose 16.37% year-over-year to -$332000.0; the trailing twelve-month figure through Mar 2026 stood at -$5.7 million (down 73.19% YoY), and the FY2025 full-year result was -$5.7 million, down 83.67% from the prior year.
  • Interest Expenses for Q1 2026 stood at -$332000.0, up from -$2.7 million in the prior quarter.
  • The five-year high for Interest Expenses was -$158000.0 in Q1 2022, with the low at -$2.7 million in Q4 2025.
  • Historically, Interest Expenses has averaged -$728352.9 across 5 years, with a median of -$397000.0 in 2025.
  • Annual changes were most pronounced in 2022 — Interest Expenses plunged 949.02% — and 2023, when it soared 65.98%.
  • Evaxion A's Interest Expenses stood at -$590000.0 in 2022, then sank by 51.69% to -$895000.0 in 2023, then surged by 48.83% to -$458000.0 in 2024, then tumbled by 500.0% to -$2.7 million in 2025, then soared by 87.92% to -$332000.0 in 2026.
  • The last three Interest Expenses figures came in at -$332000.0 (Q1 2026), -$2.7 million (Q4 2025), and -$1.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -5.50 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -332,000.00
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 61,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -2,753.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -5.58 Mn
10 Regeneron Pharmaceuticals 63.43 Bn 54.67 Bn 3.31 Bn 12.90 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -332,000.00
Mar 31, 2026 -332,000.00
Dec 31, 2025 -2.75 Mn
Dec 31, 2025 -2.75 Mn
Sep 30, 2025 -1.36 Mn
Sep 30, 2025 -1.36 Mn
Jun 30, 2025 -1.23 Mn
Jun 30, 2025 -1.23 Mn
Mar 31, 2025 -397,000.00
Mar 31, 2025 -397,000.00
Dec 31, 2024 -458,000.00
Dec 31, 2024 -458,000.00
Sep 30, 2024 -384,000.00
Sep 30, 2024 -384,000.00
Jun 30, 2024 -2.04 Mn
Jun 30, 2024 -2.04 Mn
Mar 31, 2024 -246,000.00
Mar 31, 2024 -246,000.00
Dec 31, 2023 -895,000.00
Dec 31, 2023 -895,000.00